NCT07754591

Brief Summary

The goal of this clinical trial was to compare two settings on a breathing machine used during heart surgery in children. The children in this study were born with a hole inside the heart. The hole lets extra blood flow to the lungs. Over time this can make the lungs stiffer and harder to inflate. All the children had surgery to close the hole, using a heart-lung machine. During surgery, a machine breathes for the child. It can be set in two ways. One way controls the pressure of each breath. The other way controls the amount of air in each breath. The main questions it aimed to answer were: Which setting kept the lungs easier to inflate during and after surgery? Which setting made it easier for air to move through the breathing tubes? Researchers compared children who got pressure-controlled ventilation with children who got volume-controlled ventilation, to see if lung function differed between the two groups. Participants: Had surgery to close the hole in the heart Got one of the two breathing machine settings, chosen at random Had lung measurements taken at eight points, from just after the breathing tube was placed until they were ready to come off the machine.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 13, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 13, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

August 4, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 10, 2026

Completed
Last Updated

August 10, 2026

Status Verified

August 1, 2026

Enrollment Period

1 year

First QC Date

August 4, 2026

Last Update Submit

August 4, 2026

Conditions

Keywords

Pressure-controlled ventilationVolume-controlled ventilationDynamic complianceAirway resistanceRespiratory mechanicsPediatric cardiac surgeryCardiopulmonary bypassLeft-to-right shunt

Outcome Measures

Primary Outcomes (3)

  • Airway resistance

    Airway resistance derived from ventilator measurements, expressed in cm H2O/L/second

    Eight perioperative timepoints: immediate post-intubation, ten minutes post-intubation, pre-sternotomy, pre-bypass, immediate post-bypass, five minutes after protamine administration, post-sternal closure, and pre-weaning from mechanical ventilation

  • Dynamic compliance

    Dynamic respiratory system compliance derived from ventilator measurements, expressed in mL/cm H2O

    Eight perioperative timepoints: immediate post-intubation, ten minutes post-intubation, pre-sternotomy, pre-bypass, immediate post-bypass, five minutes after protamine administration, post-sternal closure, and pre-weaning from mechanical ventilation

  • PaO2/FiO2 ratio

    Ratio of arterial partial pressure of oxygen to fraction of inspired oxygen, calculated from arterial blood gas analysis, expressed in mmHg

    Eight perioperative timepoints: immediate post-intubation, ten minutes post-intubation, pre-sternotomy, pre-bypass, immediate post-bypass, five minutes after protamine administration, post-sternal closure, and pre-weaning from mechanical ventilation

Secondary Outcomes (1)

  • Mean Airway Pressure

    Eight perioperative timepoints: immediate post-intubation, ten minutes post-intubation, pre-sternotomy, pre-bypass, immediate post-bypass, five minutes after protamine administration, post-sternal closure, and pre-weaning from mechanical ventilation

Study Arms (2)

Group P - Pressure Controlled Ventilation

ACTIVE COMPARATOR

Inspiratory pressure titrated to achieve a tidal volume of 6-8 mL/kg while keeping peak inspiratory pressure at or below 30 cm H2O, with an inspiratory-to-expiratory ratio of 1:2 and respiratory rate adjusted to maintain end-tidal carbon dioxide at 35-45 mmHg.

Other: Pressure Controlled Ventilation

Group V - Volume Controlled Ventilation

ACTIVE COMPARATOR

Tidal volume set at 6-8 mL/kg, with an inspiratory-to-expiratory ratio of 1:2 and respiratory rate adjusted to maintain end-tidal carbon dioxide at 35-45 mmHg.

Other: Volume Controlled Ventilation

Interventions

Mechanical ventilation with inspiratory pressure titrated to achieve a tidal volume of 6-8 mL/kg, with peak inspiratory pressure kept at or below 30 cm H2O.

Also known as: PCV
Group P - Pressure Controlled Ventilation

Mechanical ventilation with tidal volume set at 6-8 mL/kg.

Also known as: VCV
Group V - Volume Controlled Ventilation

Eligibility Criteria

Age1 Month - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Paediatric patients aged 1 month to 18 years
  • Left-to-right intracardiac shunt lesions (atrial septal defect or ventricular septal defect) undergoing corrective surgery under cardiopulmonary bypass - Elevated pulmonary artery pressure: pulmonary artery systolic pressure 30 mmHg or above, and/or mean pulmonary artery pressure 20 mmHg or above

You may not qualify if:

  • Refusal to participate
  • Presence of any other associated cardiac anomaly
  • Allergy to milrinone
  • Associated coagulation disorder
  • Sepsis
  • Neurological disorder
  • Hepatic or renal dysfunction
  • Failure to wean from cardiopulmonary bypass

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nil Ratan Sircar Medical College and Hospital

Kolkata, West Bengal, 700014, India

Location

MeSH Terms

Conditions

Heart Septal Defects, AtrialHeart Septal Defects, VentricularHypertension, PulmonaryHeart Septal Defects

Condition Hierarchy (Ancestors)

Heart Defects, CongenitalCardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesLung DiseasesRespiratory Tract DiseasesHypertensionVascular Diseases

Study Officials

  • Prateek Purkayastha, MBBS, MD

    Nilratan Sircar Medical College

    PRINCIPAL INVESTIGATOR
  • Sampa Dutta Gupta, MBBS, MD, PDCC, PhD

    Nilratan Sircar Medical College

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Intraoperative and postoperative data were recorded by an independent observer blinded to group allocation, and analysis used anonymised datasets. The anaesthesiologist managing ventilation could not be blinded, since ventilator settings are visible during use.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Pair-matched parallel-group design. Participants were matched on age, sex and type of left-to-right intracardiac shunt lesion. One member of each matched pair was allocated by concealed coin toss and the other assigned to the alternate group.
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
DM Post-doctoral Trainee, Department of Cardiac Anaesthesia

Study Record Dates

First Submitted

August 4, 2026

First Posted

August 10, 2026

Study Start

July 13, 2024

Primary Completion

July 13, 2025

Study Completion

December 31, 2025

Last Updated

August 10, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared. The study was approved by the Institutional Ethics Committee on the basis of a participant information sheet and consent form that provide for confidentiality of health-related information and non-disclosure of participant identity, and which do not include consent for the transfer of individual participant data to third parties. Sharing of IPD would therefore require a protocol amendment and fresh ethics approval, which has not been sought. Aggregate results will be made available through publication.

Locations